GSK (LON:GSK) Reaches New 12-Month Low at $13.92

GSK plc (LON:GSK)’s stock price reached a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 13.92 ($0.18) and last traded at GBX 1,391.20 ($17.54), with a volume of 1314462 shares. The stock had previously closed at GBX 1,388.80 ($17.51).

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on GSK shares. JPMorgan Chase & Co. reduced their price target on GSK from GBX 1,400 ($17.65) to GBX 1,300 ($16.39) in a research report on Tuesday, August 1st. Bank of America reduced their price target on GSK from GBX 1,450 ($18.28) to GBX 1,390 ($17.52) in a research report on Monday, July 17th. Shore Capital reaffirmed a “buy” rating on shares of GSK in a research note on Friday, June 16th. Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 1,575 ($19.85) price objective on shares of GSK in a research note on Monday, June 26th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,700 ($21.43) price objective on shares of GSK in a research note on Thursday, June 8th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, GSK has a consensus rating of “Hold” and a consensus price target of GBX 1,560 ($19.66).

GSK Price Performance

The company has a 50 day simple moving average of GBX 1,368.74 and a 200-day simple moving average of GBX 1,409.85. The stock has a market cap of £56.89 billion, a price-to-earnings ratio of 1,092.60, a P/E/G ratio of 0.97 and a beta of 0.31. The company has a current ratio of 0.88, a quick ratio of 0.73 and a debt-to-equity ratio of 176.61.

GSK Announces Dividend

The company also recently declared a dividend, which will be paid on Thursday, October 12th. Shareholders of record on Thursday, August 17th will be paid a GBX 14 ($0.18) dividend. This represents a dividend yield of 1.01%. The ex-dividend date of this dividend is Thursday, August 17th. GSK’s dividend payout ratio is 4,409.45%.

Insider Buying and Selling at GSK

In related news, insider Jonathan Symonds acquired 6,000 shares of the firm’s stock in a transaction dated Friday, June 23rd. The stock was bought at an average price of GBX 1,440 ($18.15) per share, for a total transaction of £86,400 ($108,912.14). In related news, insider Jonathan Symonds acquired 6,000 shares of the firm’s stock in a transaction dated Friday, June 23rd. The stock was bought at an average price of GBX 1,440 ($18.15) per share, for a total transaction of £86,400 ($108,912.14). Also, insider Hal Barron sold 19,446 shares of the firm’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of GBX 3,462 ($43.64), for a total value of £673,220.52 ($848,632.95). Insiders have bought 6,027 shares of company stock valued at $8,676,567 in the last 90 days. 1.74% of the stock is currently owned by company insiders.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.